• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Should we rename low risk cancers?

作者信息

Esserman Laura J, Varma Murali

机构信息

UCSF Carol Franc Buck Breast Care Center, San Francisco, CA, USA

Department of Cellular Pathology, University Hospital of Wales, Cardiff, UK

出版信息

BMJ. 2019 Jan 23;364:k4699. doi: 10.1136/bmj.k4699.

DOI:10.1136/bmj.k4699
PMID:30674473
Abstract
摘要

相似文献

1
Should we rename low risk cancers?我们应该重新命名低风险癌症吗？
BMJ. 2019 Jan 23;364:k4699. doi: 10.1136/bmj.k4699.
2
Diagnostic drift in the reporting of cancer incidence.癌症发病率报告中的诊断偏移。
J Natl Cancer Inst. 1998 Jun 3;90(11):863-4. doi: 10.1093/jnci/90.11.863.
3
Experts debate message sent by increased cancer survival rates.专家们就癌症生存率提高所传达的信息展开辩论。
J Natl Cancer Inst. 2004 Oct 6;96(19):1412-3. doi: 10.1093/jnci/96.19.1412.
4
What Do "None," "Mild," "Moderate," "Severe," and "Very Severe" Mean to Patients With Cancer? Content Validity of PRO-CTCAE™ Response Scales.“无”“轻度”“中度”“重度”和“极重度”对癌症患者意味着什么？PRO-CTCAE™反应量表的内容效度。
J Pain Symptom Manage. 2018 Mar;55(3):e3-e6. doi: 10.1016/j.jpainsymman.2017.10.024. Epub 2017 Nov 10.
5
Redefining "rare" in paediatric cancers.重新定义儿童癌症中的“罕见”。
Lancet Oncol. 2016 Feb;17(2):138-139. doi: 10.1016/S1470-2045(15)00538-0.
6
The F-word.那个以F开头的词。
Oncology (Williston Park). 2013 Sep;27(9):922-3.
7
Glossary of essential terms used in cancer screening.癌症筛查中使用的基本术语词汇表。
Eur J Cancer. 2011 Sep;47 Suppl 3:S171-5. doi: 10.1016/S0959-8049(11)70161-7.
8
Examining psychosocial factors related to cancer incidence and progression: in search of the silver lining.研究与癌症发病率和进展相关的社会心理因素：寻找一线希望。
Brain Behav Immun. 2003 Feb;17 Suppl 1:S109-11. doi: 10.1016/s0889-1591(02)00076-4.
9
Overdiagnosis and overtreatment in cancer: an opportunity for improvement.癌症中的过度诊断和过度治疗：改进的契机。
JAMA. 2013 Aug 28;310(8):797-8. doi: 10.1001/jama.2013.108415.
10
Incidence and risk factors for psychiatric comorbidity among people newly diagnosed with cancer based on Korean national registry data.基于韩国国家登记数据的癌症新诊断患者精神疾病共病的发病率及危险因素
Psychooncology. 2015 Dec;24(12):1808-14. doi: 10.1002/pon.3865. Epub 2015 Jun 4.

引用本文的文献

1
Mammography screening and incidence of ductal carcinoma in situ of the breast in Italy: an age-period-cohort analysis.意大利乳腺钼靶筛查与乳腺导管原位癌发病率：年龄-时期-队列分析
Int J Epidemiol. 2025 Jun 11;54(4). doi: 10.1093/ije/dyaf102.
2
Preferred labels and language to improve communication about lesions at low risk of progressing to cancer: qualitative interviews with patients and physicians.用于改善关于进展为癌症低风险病变的沟通的首选标签和语言：对患者和医生的定性访谈
BMJ Open. 2025 Jan 2;15(1):e087484. doi: 10.1136/bmjopen-2024-087484.
3
Risk perception of patients with ductal carcinoma (DCIS) of the breast and their healthcare practitioners: The importance of histopathological terminology, and the gaps in our knowledge.
乳腺导管原位癌（DCIS）患者及其医护人员的风险认知：组织病理学术语的重要性以及我们知识上的差距。
Histol Histopathol. 2025 Mar;40(3):297-306. doi: 10.14670/HH-18-806. Epub 2024 Sep 3.
4
Pituitary adenoma or neuroendocrine tumour: the need for an integrated prognostic classification.垂体腺瘤或神经内分泌肿瘤：综合预后分类的必要性。
Nat Rev Endocrinol. 2023 Nov;19(11):671-678. doi: 10.1038/s41574-023-00883-8. Epub 2023 Aug 17.
5
Should low-risk DCIS lose the cancer label? An evidence review.低危 DCIS 是否应该去掉“癌症”标签？一项证据回顾。
Breast Cancer Res Treat. 2023 Jun;199(3):415-433. doi: 10.1007/s10549-023-06934-y. Epub 2023 Apr 19.
6
Low-risk prostate lesions: An evidence review to inform discussion on losing the "cancer" label.低危前列腺病变：一项旨在为“去癌症化”讨论提供证据的综述。
Prostate. 2023 May;83(6):498-515. doi: 10.1002/pros.24493. Epub 2023 Feb 22.
7
Does including histological outcomes in a multiparametric MRI report improve prostate biopsy decision making?多参数 MRI 报告中包含组织学结果是否能改善前列腺活检决策？
Br J Radiol. 2023 Mar 1;96(1144):20220395. doi: 10.1259/bjr.20220395.
8
Behaviour within a Clinical Trial and Implications for Mammography Guidelines.临床试验中的行为及其对乳腺钼靶检查指南的影响。
Rev Econ Stud. 2023 Jan;90(1):432-462. doi: 10.1093/restud/rdac022. Epub 2022 May 9.
9
Incidental findings in medical imaging.医学影像中的偶然发现。
Br J Radiol. 2023 Feb;96(1142):20211352. doi: 10.1259/bjr.20211352. Epub 2022 Feb 4.
10
Do we need to rethink the diagnoses melanoma in situ and severely dysplastic naevus?我们是否需要重新思考原位黑素瘤和重度发育异常痣的诊断？
Br J Dermatol. 2022 Jun;186(6):1030-1032. doi: 10.1111/bjd.21010. Epub 2022 Apr 7.